|
May 6, 2021
|
Progenity to Report First Quarter 2021 Financial Results and Provide Corporate Update
|
|
May 5, 2021
|
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
|
|
May 4, 2021
|
Survey Reveals Pregnant Women Lack Awareness About Preeclampsia, the #2 Cause of Maternal Death
|
|
April 30, 2021
|
Progenity Presents Key Verification Study Data for Preecludia™ Preeclampsia Rule-out Test at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
|
|
April 26, 2021
|
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
|
|
April 8, 2021
|
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
|
|
April 6, 2021
|
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
|
|
March 18, 2021
|
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
|
|
March 12, 2021
|
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
|
|
February 23, 2021
|
Progenity Announces $25 Million Private Placement
|
